In the BioHarmony Drug Report Database

"Preview" Icon

Pegfilgrastim

Neulasta, Neulasta Onpro (pegfilgrastim) is a protein pharmaceutical. Pegfilgrastim was first approved as Neulasta on 2002-01-31. It is used to treat neutropenia in the USA. It has been approved in Europe to treat neoplasms and neutropenia. The pharmaceutical is active against granulocyte colony-stimulating factor receptor.

 

Trade Name

 

Neulasta
 

Common Name

 

pegfilgrastim
 

ChEMBL ID

 

CHEMBL1201568
 

Indication

 

neoplasms, neutropenia
 

Drug Class

 

Colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF); PEGylated compounds

Image (chem structure or protein)

Pegfilgrastim structure rendering